Still not right!

Quote

Anonymous

Guest
While I greatly appreciate the fact that Mr. Keller and his team have "revised" the S2 comp plan, I believe that they still do not have it right and most importantly, fair. While I appreciate that the threshold has been reduced from 288 syringes to 205 to meet goal and that the dollar amounts to be paid out per syringe went up (40%), the bottom line is in his closing statement.

Mr. Keller stated that he and his team recognize that "one size does not fit all". True. However the BHBU has what, 460 territories? Which means that the 205 threshold for territory 1 or 156 or 460 or pick a territory is not an accurate representation of how a comp plan should be devised. I for one, do not have a territory with NOL's or even KOL's to speak of. I for one, do not have a territory with a lot of Medicare or Critical Access Hospitals so why should my threshold be the same as the territories that do have those components?

Heck, look at the next VP report and you will see that there will be approximately 3-5 people that will be almost at 205 syringes semester-to-date.

The huge mistake here and what I was really hoping to see change with the comp plan was to go to a market share gain comp plan. Such as, grow your territory x % and you make x $'s and so on. At least that puts everyone much closer on the same playing field compared to what it is now.

Just my opinion. It has hasn't "motivated" me anymore today than yesterday! And before some of you jerks go off on me, save it! You know it's not perfect either!
 






Anonymous said:
While I greatly appreciate the fact that Mr. Keller and his team have "revised" the S2 comp plan, I believe that they still do not have it right and most importantly, fair. While I appreciate that the threshold has been reduced from 288 syringes to 205 to meet goal and that the dollar amounts to be paid out per syringe went up (40%), the bottom line is in his closing statement.

Mr. Keller stated that he and his team recognize that "one size does not fit all". True. However the BHBU has what, 460 territories? Which means that the 205 threshold for territory 1 or 156 or 460 or pick a territory is not an accurate representation of how a comp plan should be devised. I for one, do not have a territory with NOL's or even KOL's to speak of. I for one, do not have a territory with a lot of Medicare or Critical Access Hospitals so why should my threshold be the same as the territories that do have those components?

Heck, look at the next VP report and you will see that there will be approximately 3-5 people that will be almost at 205 syringes semester-to-date.

The huge mistake here and what I was really hoping to see change with the comp plan was to go to a market share gain comp plan. Such as, grow your territory x % and you make x $'s and so on. At least that puts everyone much closer on the same playing field compared to what it is now.

Just my opinion. It has hasn't "motivated" me anymore today than yesterday! And before some of you jerks go off on me, save it! You know it's not perfect either!
Click to expand...

True, a perfect comp plan is never reached no matter where you are, but please give the new leadership a chance to right was has been wrong for so very long. I found his message to be very motivating and just hearing from him has given me hope that Amgen is truly behind this product completely.

As per the VP report, do not hold your breath. We will not be getting them moving forward.

Lovingly,

MAS Jerkoff
 






Anonymous said:
While I greatly appreciate the fact that Mr. Keller and his team have "revised" the S2 comp plan, I believe that they still do not have it right and most importantly, fair. While I appreciate that the threshold has been reduced from 288 syringes to 205 to meet goal and that the dollar amounts to be paid out per syringe went up (40%), the bottom line is in his closing statement.

Mr. Keller stated that he and his team recognize that "one size does not fit all". True. However the BHBU has what, 460 territories? Which means that the 205 threshold for territory 1 or 156 or 460 or pick a territory is not an accurate representation of how a comp plan should be devised. I for one, do not have a territory with NOL's or even KOL's to speak of. I for one, do not have a territory with a lot of Medicare or Critical Access Hospitals so why should my threshold be the same as the territories that do have those components?

Heck, look at the next VP report and you will see that there will be approximately 3-5 people that will be almost at 205 syringes semester-to-date.

The huge mistake here and what I was really hoping to see change with the comp plan was to go to a market share gain comp plan. Such as, grow your territory x % and you make x $'s and so on. At least that puts everyone much closer on the same playing field compared to what it is now.

Just my opinion. It has hasn't "motivated" me anymore today than yesterday! And before some of you jerks go off on me, save it! You know it's not perfect either!
Click to expand...

I love the people who take a good thing and try to twist it into a bad thing. The goal was reduced by 30%!! how many companies reduce goals at all? Let's suppose we went with the poster above and did the market share increase. That means someone who is at 4% and moves to 6% increases their market share by 50% and should somehow deserve a windfall - more than the territory that is currently chugging along at 10% and moves to 12% - even though the 10% territory is driving way more dollars for the company than the 4%. How is that fair?? Someone who is cranking and cranking since launch (without KOLs) should get penalized? Hardly fair. Your assumption is that all reps are equal and they aren't!
 












Plain and simple . Mr Keller nice move collectively, but we have enough data for HISTORY now and have been. Go to a quota system like the rest of the business units and lets get the payment similar to the rest of the units.

Your giving the same people who blow this number out a smaller number to come up with. why don't you see if that same territory can sustain a 30 to 40 increase over what THEY did last qtr. year etc. you have the data set now.
 






Anonymous said:
I love the people who take a good thing and try to twist it into a bad thing. The goal was reduced by 30%!! how many companies reduce goals at all? Let's suppose we went with the poster above and did the market share increase. That means someone who is at 4% and moves to 6% increases their market share by 50% and should somehow deserve a windfall - more than the territory that is currently chugging along at 10% and moves to 12% - even though the 10% territory is driving way more dollars for the company than the 4%. How is that fair?? Someone who is cranking and cranking since launch (without KOLs) should get penalized? Hardly fair. Your assumption is that all reps are equal and they aren't!
Click to expand...

You missed the point DUMBASS
 


















Anonymous said:
IBU has quotas.... and some territories have only 10 Rheums or less.
Click to expand...

They have quotas because they have a high penetration of >60%, which means it's easy to give quotas when you reach a highly penetrated market. Not the case with PCPs. Not even close. They also have a $3.5B product called Enbrel that makes up 70% of their bonus.
 












So by your account, we will be getting fucked for sometime? If this is the case, now you know why people are leaving.They spend all this money on training, rapport building and people have left like a whirlpool in ALL div.

Anonymous said:
They have quotas because they have a high penetration of >60%, which means it's easy to give quotas when you reach a highly penetrated market. Not the case with PCPs. Not even close. They also have a $3.5B product called Enbrel that makes up 70% of their bonus.
Click to expand...
 






I like the new comp plan for now. It needed to be changed for S2 and it was. Next year they can look at % change. But the most glaring issue is S1. Around 30% of people will get ZERO dollars in September, even if they sold 90 syringes, if they met the Q1 goal. That is ridiculous. The door is never closed on the previous semester. That needed to be fixed. I like the new plan, but if an offer comes, I'm going.
 






Anonymous said:
I like the new comp plan for now. It needed to be changed for S2 and it was. Next year they can look at % change. But the most glaring issue is S1. Around 30% of people will get ZERO dollars in September, even if they sold 90 syringes, if they met the Q1 goal. That is ridiculous. The door is never closed on the previous semester. That needed to be fixed. I like the new plan, but if an offer comes, I'm going.
Click to expand...

Tell you what, if you can find a company that guarantees you a salary and a bonus for the rest of your life OR even a year you should go for it. oh yea that's welfare, mmmm kinda gives us perspective on how you want to earn your living.
 






Anonymous said:
I like the new comp plan for now. It needed to be changed for S2 and it was. Next year they can look at % change. But the most glaring issue is S1. Around 30% of people will get ZERO dollars in September, even if they sold 90 syringes, if they met the Q1 goal. That is ridiculous. The door is never closed on the previous semester. That needed to be fixed. I like the new plan, but if an offer comes, I'm going.
Click to expand...

And what company, in any industry, retroactively takes down goals? 90 syringes in Q1? - they got paid in June and it was projected out as if they would repeat the same performance in Q2. So those folks who sold 90 syringes in Q1 actually would owe money to Amgen, which Amgen will not collect!
 






How about , we just sell what we can, and they pay us X amount(Per syringe) until they go to a saturated Quota plan. I realize we have to have a goal , but by the time we get the info we are already 2-3 weeks out. If some territories are golden fine, we know not all territories are equal. We should have enough of a saturated plan close to first quarter next year. They change this Shit every month? It shows how much AYTO really does not know about Primary care in general. ONE thing we all KNOW is that one size does not fit all!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Anonymous said:
And what company, in any industry, retroactively takes down goals? 90 syringes in Q1? - they got paid in June and it was projected out as if they would repeat the same performance in Q2. So those folks who sold 90 syringes in Q1 actually would owe money to Amgen, which Amgen will not collect!
Click to expand...
 






Anonymous said:
How about , we just sell what we can, and they pay us X amount(Per syringe) until they go to a saturated Quota plan. I realize we have to have a goal , but by the time we get the info we are already 2-3 weeks out. If some territories are golden fine, we know not all territories are equal. We should have enough of a saturated plan close to first quarter next year. They change this Shit every month? It shows how much AYTO really does not know about Primary care in general. ONE thing we all KNOW is that one size does not fit all!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Click to expand...

Are you kidding? Just sell what you can? Again, what publicly traded company tells their sales force to "just sell what you can?" What's so special about selling in primary care? - you have to convince a customer to use your product. That's sales. It doesn't matter if you're selling a commodity product or a unique product, you develop a relationship with your customer, understand their needs, tailor the many benefits of your product to those needs, answer concerns they may have, and find appropriate patients that the doc feels comfortable with. Then expand usage. Every product has it's pros and cons (except maybe Apple). They have already stated they will be moving to territory goals next semester. Go make some commission and they will pay for every syringe you sell, just alot more if you sell alot more. How does that not make sense?
 






Anonymous said:
Are you kidding? Just sell what you can? Again, what publicly traded company tells their sales force to "just sell what you can?" What's so special about selling in primary care? - you have to convince a customer to use your product. That's sales. It doesn't matter if you're selling a commodity product or a unique product, you develop a relationship with your customer, understand their needs, tailor the many benefits of your product to those needs, answer concerns they may have, and find appropriate patients that the doc feels comfortable with. Then expand usage. Every product has it's pros and cons (except maybe Apple). They have already stated they will be moving to territory goals next semester. Go make some commission and they will pay for every syringe you sell, just alot more if you sell alot more. How does that not make sense?
Click to expand...

Dude, you lost all credibility when you stated that apple doesn't have any cons. Yeah, they are "perfect" Whatever!
 






Anonymous said:
Dude, you lost all credibility when you stated that apple doesn't have any cons. Yeah, they are "perfect" Whatever!
Click to expand...

You're focusing on the Apple statement? Ok. Ignore that and tell me what else isn't credible. It was sarcastic. Every product has cons. But Apple - currently the world's most valuable company after being near bankruptcy - doesn't have many and they have met customer's needs better than almost any other company, as seen in the results of their stock performance. Up 10,000% in a decade of zero growth in the stock market. How is The Apple example so "out there?"

Your "whatever" argument is the worthless argument. Come up with something better than "dude" and "whatever."
 






Okay you suck and your Mom is a man , hows that, the guy a few posts up has it right we are selling what we can, and obviously with a butt load of people leaving this org. just take a good look buttloaf.



Anonymous said:
You're focusing on the Apple statement? Ok. Ignore that and tell me what else isn't credible. It was sarcastic. Every product has cons. But Apple - currently the world's most valuable company after being near bankruptcy - doesn't have many and they have met customer's needs better than almost any other company, as seen in the results of their stock performance. Up 10,000% in a decade of zero growth in the stock market. How is The Apple example so "out there?"

Your "whatever" argument is the worthless argument. Come up with something better than "dude" and "whatever."
Click to expand...
 






Anonymous said:
Okay you suck and your Mom is a man , hows that, the guy a few posts up has it right we are selling what we can, and obviously with a butt load of people leaving this org. just take a good look buttloaf.
Click to expand...

The perfect example of what happens when bad hiring decisions are made! No intelligence, no motivation, no relevant skill set, no ability to learn. Nice work "Right Thing", your process gave us a bunch of resume liars from pods. Awesome.
 






Top Bottom
Back
Quote